DK1159270T3 - Process for the preparation of 1- (6-methylpyridin-3-yl) -2 - [(4- (methylsulfonyl) phenyl] ethanone - Google Patents

Process for the preparation of 1- (6-methylpyridin-3-yl) -2 - [(4- (methylsulfonyl) phenyl] ethanone

Info

Publication number
DK1159270T3
DK1159270T3 DK00901555T DK00901555T DK1159270T3 DK 1159270 T3 DK1159270 T3 DK 1159270T3 DK 00901555 T DK00901555 T DK 00901555T DK 00901555 T DK00901555 T DK 00901555T DK 1159270 T3 DK1159270 T3 DK 1159270T3
Authority
DK
Denmark
Prior art keywords
methylpyridin
preparation
ethanone
methylsulfonyl
phenyl
Prior art date
Application number
DK00901555T
Other languages
Danish (da)
Inventor
Erich Armbruster
Yves Bessard
David Kuo
James Edward Leresche
Ralf Proplesch
Jean-Paul Roduit
Original Assignee
Lonza Ag
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag, Merck & Co Inc filed Critical Lonza Ag
Application granted granted Critical
Publication of DK1159270T3 publication Critical patent/DK1159270T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Abstract

1-(6-Methylpyridin-3-yl)-2-(4-methylsulfonyl-phenyl)-ethanone is new. 1-(6-methylpyridin-3-yl)-2-(4-methylsulfonyl-phenyl)-ethanone of formula (I) is new: Independent claims are also included for the following: (a) a 4-step preparation of (I) where the third step for the preparation of N,N-dialkylamino-(6-methyl-3-pyridyl)acetonitriles of formula (III) and the last step are claimed per se; (b) compounds (III); (c) alkali metal 1-hydroxy-(6-methylpyridin-3-yl)methanesulfonate intermediates of formula (II) (for preparing (III)); (d) preparation of (II) comprising treating 2-methyl-5-vinylpyridine with ozone followed by reduction with an alkali hydrogen sulfite. R1, R2 = 1-4C alkyl; M = alkali metal.
DK00901555T 1999-01-14 2000-01-13 Process for the preparation of 1- (6-methylpyridin-3-yl) -2 - [(4- (methylsulfonyl) phenyl] ethanone DK1159270T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99100590 1999-01-14
US14599699P 1999-07-29 1999-07-29

Publications (1)

Publication Number Publication Date
DK1159270T3 true DK1159270T3 (en) 2004-02-23

Family

ID=34089809

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00901555T DK1159270T3 (en) 1999-01-14 2000-01-13 Process for the preparation of 1- (6-methylpyridin-3-yl) -2 - [(4- (methylsulfonyl) phenyl] ethanone
DK03024787T DK1394149T3 (en) 1999-01-14 2000-01-13 Process for the preparation of 1- (6-methylpyridin-3-yl) -2- [4- (methylsulfonyl) phenyl] ethanone

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03024787T DK1394149T3 (en) 1999-01-14 2000-01-13 Process for the preparation of 1- (6-methylpyridin-3-yl) -2- [4- (methylsulfonyl) phenyl] ethanone

Country Status (15)

Country Link
EP (2) EP1159270B1 (en)
JP (1) JP4765167B2 (en)
CN (2) CN1281589C (en)
AT (2) ATE287396T1 (en)
AU (1) AU2290800A (en)
CA (2) CA2485739C (en)
CZ (1) CZ302270B6 (en)
DE (2) DE50009312D1 (en)
DK (2) DK1159270T3 (en)
ES (2) ES2209807T3 (en)
HU (1) HUP0105124A3 (en)
IL (1) IL143981A0 (en)
PT (2) PT1159270E (en)
SK (1) SK284903B6 (en)
WO (1) WO2000042014A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104725300A (en) * 2015-02-28 2015-06-24 宁波九胜创新医药科技有限公司 Preparation method of 1-(6-methyl pyridine-3-yl)-2-(4-methylsulfonyl phenyl) ethanone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313683A (en) * 1963-04-22 1967-04-11 Lilly Co Eli Nematocidal and fungicidal methods
FR2074674A1 (en) * 1970-01-16 1971-10-08 Simafex Sulphonamide/aldehyde-bisulphite complexes - antibacterials with very high solubility in water
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
BRPI9710372B8 (en) * 1996-07-18 2021-05-25 Merck Canada Inc compound, and, pharmaceutical composition.
TW492959B (en) * 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
AR015938A1 (en) * 1997-09-25 2001-05-30 Merck Sharp & Dohme PROCEDURE TO PREPARE DIARIL PIRIDINES USEFUL AS COX-2 INHIBITORS AND INTERMEDIATE COMPOUND
KR100414998B1 (en) * 1998-04-24 2004-01-13 머크 앤드 캄파니 인코포레이티드 Process for synthesizing COX-2 inhibitors

Also Published As

Publication number Publication date
SK284903B6 (en) 2006-02-02
CZ20012457A3 (en) 2002-01-16
CN1359374A (en) 2002-07-17
CA2359958C (en) 2006-04-04
CA2359958A1 (en) 2000-07-20
JP4765167B2 (en) 2011-09-07
ATE253559T1 (en) 2003-11-15
EP1394149A1 (en) 2004-03-03
HUP0105124A3 (en) 2002-05-28
CN1170820C (en) 2004-10-13
AU2290800A (en) 2000-08-01
EP1159270A2 (en) 2001-12-05
DE50004327D1 (en) 2003-12-11
IL143981A0 (en) 2002-04-21
JP2003518002A (en) 2003-06-03
CA2485739C (en) 2009-09-22
CN1583723A (en) 2005-02-23
CA2485739A1 (en) 2000-07-20
ATE287396T1 (en) 2005-02-15
WO2000042014A2 (en) 2000-07-20
ES2209807T3 (en) 2004-07-01
PT1159270E (en) 2004-03-31
DK1394149T3 (en) 2005-04-04
CN1281589C (en) 2006-10-25
WO2000042014A3 (en) 2000-12-07
DE50009312D1 (en) 2005-02-24
HUP0105124A2 (en) 2002-04-29
ES2235138T3 (en) 2005-07-01
CZ302270B6 (en) 2011-01-19
EP1159270B1 (en) 2003-11-05
EP1394149B1 (en) 2005-01-19
PT1394149E (en) 2005-05-31
SK9722001A3 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
DK1188747T3 (en) Phenoxypropylamine compounds
NO20062256L (en) Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones
NO963706L (en) Benzene-condensed heterocyclic derivatives and their use
WO2005116023A8 (en) 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
NZ332057A (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds
MY147948A (en) 4- imidazolin-2-one compounds
ATE333457T1 (en) CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS
DK1159270T3 (en) Process for the preparation of 1- (6-methylpyridin-3-yl) -2 - [(4- (methylsulfonyl) phenyl] ethanone
NO971687D0 (en) Diazepinoindoles as phosphodiesterase IV inhibitors
DE60002583D1 (en) BENZOFURYL PIPERAZINE AS SEROTONIN AGONISTS
DK1335913T3 (en) Process for the preparation of pantoprazole and its intermediates
DK1165485T3 (en) Process for the preparation of pesticide intermediates
ATE470442T1 (en) USE OF GAMMA-TOCOTRIENOL AS A DIURETIC
FR2827169B1 (en) HARDENER FOR NAILS
FR2822467B1 (en) BENZOXATHIEPIN DERIVATIVES AND THEIR USE AS MEDICAMENTS
EA200100074A1 (en) METHOD OF TREATMENT OF PULMONARY HYPERTENSION
DK1117636T3 (en) Process for the preparation of trion-bis (oxime ether) derivatives and thus obtainable trion-mono- and trion-bis (oxime ether) derivatives
DK1282619T3 (en) Process for the preparation of thiazolidinedione derivatives and intermediates
MXPA01007169A (en) 1-(6- methylpyridine- 3-yl)-2-[4- (methylsulfonyl) phenyl] ethanone and method for its preparation.
ATE318823T1 (en) PHARMACEUTICALLY APPLICABLE SALTS OF 20(S)-CAMPTOTHECINES
NZ336032A (en) Diphenylalkyl-tetrahydropyridines and use in pharmaceutical compositions
ES2084643T3 (en) INDOLILPROPANOLES, PROCEDURE FOR ITS MANUFACTURE AND USE, AS WELL AS PREPARATIONS CONTAINING THE COMPOUNDS.
WO2002058632A3 (en) Primary intermediates for oxidative coloration of hair
WO2002009520A1 (en) Flowering regulators
HUP9903074A2 (en) 2-(3h)-oxazolone derivatives, process for their preparation, their use and pharmaceutical compositions containing them